High-rise commercial buildings

Sub Markets

Property Sectors

Topics

Boston & New England CRE News In Your Inbox.

Sign up for Connect emails to stay informed with CRE stories that are 150 words or less.

Boston & New England  + Massachusetts  + Office  | 

BPGbio Inks 70K-SF HQ in Waltham 

Lincoln Property Company, Cresa Boston, and BPGbio, Inc. announced BPGbio’s lease of 70,000 square feet at 300 Third Avenue in Waltham, MA. The AI-powered biopharma plans to relocate its headquarters from Framingham and expand into two full floors by June 2025. 

The new facility will house their biobank and support drug development and partnerships. 300 Third Avenue, a purpose-built life science building, offers LEED Gold certification and amenities like a roof deck and fitness center. “Our new facility will also house our 100,000+ sample rich biobank, which forms the basis of our unique biology-first, AI-powered drug development, and fuel successful partnerships with pharma, academic, and government partners.” said Niven R. Narain, Ph.D., CEO of BPGbio.  

Lincoln’s Tim Latham, Christopher Scott, and Chris Devaux represented ownership, while Cresa Boston’s Paul Delaney, Adam Subber, and Nate Heilbron represented BPGbio. The company joins Biocytogen at the site. 

Connect

Inside The Story

Tim Latham

About Emily Fu

Emily Fu is Content Director of Connect Commercial Real Estate, where she covers the east coast markets, including New York, Boston & New England, and DC & Mid-Atlantic markets. She produces daily news stories as well as longer-form content, ranging from Q&As to thought-leadership pieces. She also writes feature stories for Connect Money. With previous stints at Reuters, Seeking Alpha, and Commercial Observer, Emily has covered the finance side of the commercial real estate industry, technology, media, telecom (TMT), and fashion. She attended the Columbia Graduate School of Journalism and currently resides in Manhattan.